vertis Biotechnologie AG, founded as a spin-off of TU München-Weihenstephan university, is a research-focused organization active in the area of functional genome analysis. vertis is one of the leading companies in the fields of genome-wide RNA sequencing and extensive de-novo transcript profiling. Through years of basic research, vertis has developed innovative tools for cloning and analyzing coding (mRNA) and non-coding RNA from a wide range of organisms and starting materials, combining highest quality results with efficiency and cost effectiveness.
vertis – a partner in biotechnological and pharmaceutical research.
Address
Lise-Meitner-Straße 30
D-85354 Freising
Telefon +49 (0) 8161 14112-11
Telefax +49 (0) 8161 14112-12
info@vertis-biotech.com
www.vertis-biotech.comYear of foundation
2000
Business activity
5Executive Board
Dr. Fritz ThümmlerBusiness activity
• Ultra-tiefe RNA-Sequenzierung von
kodierenden (mRNA, Transkriptom) und nicht-kodierende RNAs (z.B. MikroRNA) aus Eukaryonten und aus Prokaryonten
• De-novo-Erstellung von genomweiten Expressionsprofilen aus MPSS-Daten
• Herstellung von qualitativ hochwertigen cDNA-Banken in einer Vielzahl von
unterschiedlichen Klonierungsvektoren
